As Global Sponsor, CooperVision’s Support Expands Language Options and Extends Access to New Markets
CooperVision, a global leader in myopia management and control, has announced its sponsorship of Ocumetra’s mEYE™ Guide, a parent conversation tool for eye care professionals (ECPs), and mEYE™ Gauge, an axial length estimator. This partnership will broaden access to the tools with additional languages, extending their capabilities to non-English speaking markets worldwide.
Despite rising global prevalence and severity of myopia, ECPs around the world recognize that parents often don’t understand the need for myopia management and find that it can take a lot of time to thoroughly explain the concept and treatment options.1
“Just as CooperVision has invested in growing a comprehensive portfolio of evidence-based myopia interventions,2-10 we are dedicated to expanding the accessibility of tools and resources that empower eye care professionals to combat childhood myopia in their practice,” said Elizabeth Lumb, BSc (Hons) MCOptom, FBCLA, Director of Global Professional Affairs, Myopia Management, CooperVision. “Our sponsorship of the Ocumetra tools will broaden access to these critical tools to help ensure the disease of myopia is treated with urgency.”
Through intuitive, visual information such as refraction centile charts and a vision simulator packaged into personalized reports, mEYE™ Guide is designed to simplify the conversation between ECPs and parents of children with myopia. With a deeper understanding of myopia, families may be more likely to choose treatment and commit long-term.
An additional Ocumetra tool, mEYE™ Gauge, is also available to ECPs. While ocular biometry remains the gold standard for tracking myopia progression, axial length estimator mEYE™ Gauge empowers ECPs to begin integrating axial length into their myopia management routine without the upfront expense of an optical biometer.
“We are excited about CooperVision’s sponsorship which will help bring mEYE™ Guide and mEYE™ Gauge to a broader global audience,” said Prof. Ian Flitcroft, D.Phil, FRCOphth, Ocumetra Co-Founder and Chief Innovation Officer. “At Ocumetra we create tools that help to accelerate the adoption of evidence-based treatments to benefit children with myopia everywhere.”
Through CooperVision’s sponsorship, mEYE™ Guide and mEYE™ Gauge will expand to support additional languages including: Traditional Chinese, Simplified Chinese, Czech, French, German, Hebrew, Hungarian, Italian, Korean, Polish, Portuguese, Russian, and Spanish. Ocumetra has plans underway for other languages as well. With these additional languages, the tools will be able to serve regions with the highest prevalence of myopia around the world.
Ocumetra’s mEYE™ Guide and mEYE™ Gauge are available on a subscription basis. A free trial (and its terms and conditions) is available at cvi.ocumetra.com. At this time, these tools are available in English only. Additional languages to be added in the near future.
# # #
CooperVision, a division of CooperCompanies (NYSE:COO), is one of the world’s leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.
CooperCompanies (“Cooper”) is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, Calif., Cooper has a workforce of roughly 14,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com
Mike McDougall, APR, Fellow PRSA, McDougall Communications
email@example.com or +1-585-434-2150